A drug called vorinostat made brain tumor cells die in the lab
Original title: Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Coordinately Modulates Cell Cycle Regulatory Genes and Intrinsic and Extrinsic Apoptotic Pathway Genes to Induce Apoptosis in Human Glioblastoma, Medulloblastoma, and Acute Lymphoblastic Leukemia Cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in cancer cells in a lab, not in people.
The short version
In lab dishes, this drug pushed brain tumor cells to die.
What was studied. Researchers tested a drug called vorinostat on cancer cells in a lab. They used cells from three cancers: glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary, medulloblastoma, and a blood cancer called acute lymphoblastic leukemia.
What they found. The drug changed how many genes worked inside these cells. Those genes help control how cells grow and when cells die. More cancer cells died in all three groups of cells.
What this means, and what it doesn't
What it could mean: It shows one possible way a drug might slow these cancers. It also adds to the case for testing this drug further. It cannot guide your care today.
What it doesn't mean: This work was done in cells in a dish, not in people. It does not show the drug helps patients live longer or feel better. It is very early science, far from day to day care. It is not a cure, and it is not a treatment you can ask for now.
Source: PubMed, September 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.